Development of risk scoring system for stratifying population for hepatocellular carcinoma screening

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|6|1934-1944

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.6, 2015-06, pp. : 1934-1944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of Background Factors and Evaluation of a Population at High Risk of Hepatocellular Carcinoma

By  

Intervirology, Vol. 46, Iss. 3, 2003-07 ,pp. : 150-156

Karger

Access to resources Recommend Favorite

Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E87-E97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: prognostic scoring systems for hepatocellular carcinoma patients – the jury is still out

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 596-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: A population‐based cohort study

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1446-1455

John Wiley & Sons Inc

Access to resources Recommend Favorite

SSRIs associated with decreased risk of hepatocellular carcinoma: A population‐based case‐control study

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 27, Iss. 1, 2018-01 ,pp. : 187-192

John Wiley & Sons Inc

Access to resources Recommend Favorite